EXICURE, INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
EXICURE, INC. (XCUR) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $0 as of 2021-09-30, per its 10-Q filed 2021-11-19.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2021-11-19
- 2021-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2021-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2021-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2020-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-19 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-06 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 |
| 2017-09-30 | $612.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |